Stay updated on BXCL701 Combo in mCRPC: SCLC/Adeno Clinical Trial
Sign up to get notified when there's something new on the BXCL701 Combo in mCRPC: SCLC/Adeno Clinical Trial page.

Latest updates to the BXCL701 Combo in mCRPC: SCLC/Adeno Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 added. The funding-status notice and the older Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedUI and metadata updates were added, including a glossary toggle, new last-update fields (Last Update Submitted that Met QC Criteria and Last Update Posted), a No FEAR Act Data section, and a Revision: v3.4.0, while the corresponding prior items (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4) were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 in the page footer.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations sections were added and updated to list study sites across the United States and the United Kingdom. The page now includes entries for multiple US states and UK regions, along with the revision tag 'Revision: v3.3.3'.SummaryDifference1%

- Check92 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2. No changes to study content, objectives, eligibility criteria, or locations are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to BXCL701 Combo in mCRPC: SCLC/Adeno Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BXCL701 Combo in mCRPC: SCLC/Adeno Clinical Trial page.